Sponsor or institution

Clinical trials and research at Groupe français d'étude des Maladies Inflammatoires de loeil

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Ustekinumab for mucocutaneous Behçet's syndrome

  This study will see if a biosimilar of ustekinumab helps adults with mucocutaneous Behçet's syndrome who are refractory to or intolerant of standard treatments, compared with patients treated with apremilast.

  Recruiting at 2 sites Groupe français d'étude des Maladies Inflammatoires de loeil · Bordeaux and 10 other locations · NCT07244614

• Using Tocilizumab for treating aortitis in Giant Cell Arteritis

  This study is testing if a new version of Tocilizumab can safely help people with Giant Cell Arteritis and active aortitis feel better while they are already on standard treatment.

  Recruiting Groupe français d'étude des Maladies Inflammatoires de loeil · Paris · NCT06271018

Quick answers

How many clinical trials run by Groupe français d'étude des Maladies Inflammatoires de loeil are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in France. Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →